Month: November 2011

Biorreguladora medicine helps prevent colds.

Biorreguladora medicine helps prevent colds.

Conference Prescribo homeopathy of the of the University of Zaragoza.

-It is estimated that more than 85% of Spaniards catches a cold at least once a year and is the major cause of labour and school absenteeism

-bioregulators medications include different active ingredients of plant origin and ore in doses equivalent to those found naturally in the immune system

Zaragoza, November 2011- biorreguladora medicine can raise defenses and thus avoid flu and colds, processes as it has become apparent in a conference organized by the Group of working Prescribo homeopathy, of the University of Zaragoza. It is estimated that more than 85% of Spaniards catches a cold at least once a year, and is the major cause of labour and school absenteeism.

Bioregulators drugs include different active ingredients of vegetable and mineral origin in doses equivalent to those found naturally in the immune system, which explains its efficacy and safety to boost defenses, according to doctor Antonio Bermudo, biorreguladora medicine specialist. An essay published in the Magazine Journal of Immune Based Therapies and Vaccines demonstrated that two drugs bioregulators, Engystol and Gripp-Heel, have demonstrated their effectiveness against the cold to act on the immune system. The cells that had previously been treated with these drugs showed greater resistance and liberated plus interferon type 1 (IFN-1) than untreated cells.

bioregulators medications contain combinations of active ingredients in low doses that stimulate the production of interferon. “ cells need this Messenger to launch the immunological defenses. In the case of Engystol his front activity has been observed to various types of cold and flu, as the virus virus respiratory syncytial (RSV), human rhinovirus (RVH) and influenza A ”, points out this specialist.

According to a study published in the latest issue of Respiratory Medicine, T and NK (natural killer) of the immune system cells have a decisive role in coordinating the response of the organism against pathogens that cause respiratory illnesses like the flu, asthma, pulmonary obstruction or pneumonia. Therefore, “ therapies aimed at stimulating and modular defenses offer new possibilities for treating these diseases ”, according to this research.

In this context, says Dr. Bermudo, “ many scholars opt for bioregulators medicines against respiratory viruses of upper tract because they already have an important scientific evidence against viral infections and lack of significant side effects ”.

biorreguladora in rhinitis medicine

not the case, adds, with pain relievers and anti-inflammatory medications used regularly in colds, whose abuse “ may cause significant digestive disorders ”.

From the Organization of the day, the coordinators of the same, the doctors José Javier Aranaz and Francisco Javier Lanuza, manifest satisfaction by the high-level scientific conferences, presentations and communications, as well as the active participation of the high number of attendees. In this edition has been 284 congressmen, doctors, pharmacists and veterinarians throughout the Spanish geography.

Read More

Menarini acquires Invida group.

Acquires Menarini group Invida.

Singapore, Florence, November 2011- Singapore, Australia, China, Hong Kong, India, Indonesia, Malaysia, New Zealand, Korea South, Taiwan, Thailand, Philippines and Viet Nam. These are the countries which opens the Italian multinational headquartered in Florencia, Menarini group, following the signing in Singapore of the contract for Invida Group Private Limited (Invida), until now in the hands of Temased Holding (a company of Asian investment Singapore-based), Quintiles (North American biotechnology and pharmacy services company) and Zuelling (leader in distribution of health in Asia).

Invida group is one of the major pharmaceutical companies with activity in the Asia Pacific region, an area which represents 10% of the global pharmaceutical market, and has a 20% annual growth. With a turnover of more than 220 million dollars (160 million euros) annually, it employs 3,500 people in template and a consolidated presence in major therapeutic areas. Invida to Menarini represents the most suitable company for your opening emerging countries with the highest rates of growth in the world. The financial terms of the transaction have not been revealed.

Development model provided by Menarini for group Invida provides, as in all purchases above, assess the identity, culture and local competences, and thus ensures Invida and its human resources based on a highly entrepreneurial vision future, dynamic and not speculative.

“ Has been a challenging negotiations to which we have worked in full in recent months ” said Alberto Giovanni Aleotti, together with the director general Piero Corsa has guided the negotiating team of Menarini. Also on this occasion our team has worked with extraordinary passion, and I take this opportunity to thank each Member of the same heart ”. For Aleotti: “ Singapore perceives the vitality of all the countries of the area and focus the best skills, thanks to policies with a vision for the future of the Governments of the area ”.

“ En Invida have found the Menarini of Asia, and a management with exceptional powers ”, discussed Piero Corsa and Domenico Simone, CEOs of Menarini, underlining the potential of the acquisition: “ have a headquarters in Singapore is ideal to create a bridge between Europe and Asia and to Asian patients carry that way all the therapeutic benefits of our medicines ”.

John Graham, CEO of Invida to continue conducting activities in the Asia Pacific area.

Lucia Aleotti, Vice-President of the Menarini group has concluded: “ this challenge we are excited about, because one side puts us before great opportunities for expansion in rapidly developing countries, and on the other hand, our group will bring new highly qualified ”.

About Menarini

Menarini group is the leading Italian pharmaceutical group in the world, settling in the 15th place of 4.881 European companies and ranked 34 of 14.051 companies in the world by turnover, according to data from 2010. Last year the company invoiced 3,031 million euros. The company employs 12.890 workers, of which 91% are graduates and technical specialists. Menarini group has always pursued two strategic objectives: research and internationalization. both targets have enabled Menarini results highlighted in the global market; as well as reinvested in research and innovation of new drugs, making them available to patients around the world.

With a presence in over 100 countries, Menarini group is responsible for the needs of patients and specialist health care in the following therapeutic areas: cardiovascular, Gastroenterology, antibiotics, in the respiratory field, products for the treatment of diabetes, anti-inflammatory drugs and analgesics.

On group Invida

Invida improves the lives of the patients in Asia through the marketing of prescription drugs and pharmaceutical advertising specialties (EFP). As a result of this acquisition, all shareholders will grow with the company. All this has been a careful plan of brand marketing and a know-how applied to sales, combined with extensive experience in therapeutic areas key and deep knowledge of the Asian market.

About 3,500 employees in 13 Asia-Pacific markets, Invida operates throughout the production chain from regulatory to launch the product approval through the management of the life of the drug. Manages a broad participation in other brands of products approved, from small to large biotech companies and health multinational. Partnering is the key to the business model of Invida. It works closely with partners, to develop effective strategies and putting his extensive experience as a backup to maximize the assets entrusted to them.

Read More

“Take a minute” for your health on World COPD day.

“ Take a minute ” for your health at the world day of COPD.

16 November: day world of the disease pulmonary obstructive chronic.

– the 16 of November was celebrated the day world of disease pulmonary obstructive chronic (COPD) under the motto “ known and breathes ”

-pulmonologist Carlos Ruiz Martínez Hospital Viamed Los Manzanos has proposed, the activities to publicize the illness, a brief questionnaire that will help you know if you have COPD

-La COPD kills 50 people a day in Spain and in La Rioja, 14,000 persons affected by this disease are

– despite its high incidence, 80% of Spaniards do not know what is this disease or known risks

Logroño, November 2011- every day, 50 people die in Spain his fault, but few Spaniards know what it is. Only two out of every ten Spaniards know what they talking about to mention the acronym COPD, a disease that mainly affects smokers, which is the fifth leading cause of mortality in developed countries and which will become the third by 2020, according to the World Health Organization (who).

the disease pulmonary obstructive chronic, responds to these four acronyms, is charged in Spain every year more than 18,000 lives, eight times more than traffic accidents. More than two million people suffer and often nor they know: is only diagnosed in one of every four cases. Being 80% of the Spaniards ignored, according to a poll more than 6,500 people by the Spanish society for Thoracic Surgery (Separ) and pneumonia.

Chronic cough, expectoration, repeated colds and dyspnea (lack of air, often to make some effort) are symptoms that should see a specialist.

“Diagnose is very easy, just a spirometry ”, explains the pulmonologist of Hospital Viamed Los Manzanos, Carlos Ruiz Martínez on the occasion of the world day, which was held on 16 November.” “What happens is that often the smoker attributed these symptoms to tobacco, becomes greater and find them normal.” “But they are not always and life can be much improved with treatment,” added.

Although in principle anyone can suffer from COPD, it is much more common among smokers, who represent 80% of patients. Between 15% and 20% who consume or have consumed tobacco normally they will suffer from this disease.

Carlos Ruiz Martínez pulmonologist ensures that abandoning tobacco is the most effective way to not suffer a COPD. It is also to halt their advance once detected. Patients who stop it in its early stage have much better quality of life, added the specialist.

Dr. Ruiz.

“ Is very important to know your symptoms in order to combat ” said the specialist and why in the World COPD day proposed a short and simple questionnaire developed by GOLD (The Global Initiative for Chronic Obstructive Lung Disease) and scientifically evaluated to identify the person most likely to have COPD ”. The questionnaires will be available to the public tomorrow in Hospital Viamed Los Manzanos.

On World COPD day take a minute to solve this questionnaire.

Obstructive lung disease chronic (COPD) is a serious disease. However, many people suffer from it and not know it. These questions will help you know if you might have COPD.

It is a short questionnaire developed by GOLD (The Global Initiative for Chronic Obstructive Lung Disease) and scientifically evaluated to identify the person most likely to have COPD.

1. what cough most days?

2 start phlegm often?

3. What is more easily than others their age fatigue?

4. do you have more than 40 years?

5. smoke or has smoked?

“If it responds affirmatively to three or more than these five questions it follows that you may have COPD and therefore call the doctor to confirm through a spirometry”

according to the national educational programme for United States, the spirometry lung health should take place in the ambulatory the majority of smokers, that early detection of COPD in smokers may change the progression of the disease. The spirometry is capable of detecting disorders of mild, but clinically important, air flow in about 20% of smokers without symptoms. These patients could prevent the decline of their lung function if they avoid tobacco. Currently, we recommend you a spirometry for all patients of any age who have symptoms of COPD and all smokers over age 40 who have risk factors: smoking, recent former smokers and people with occupational exposure to toxic pulmonary agents.

Read More

Ana Belén amadrina calendar twelve Cinderellas by 2012 for the Foundation, Down syndrome, Madrid.

Ana Belén amadrina calendar twelve Cinderellas by 2012 for the Foundation syndrome of Down in Madrid.

pastora Vega, Laura Sanchez, Dafne Fernández, Eloy Azorín and Adrià Collado, among others, have joined this solidarity. initiative

– the benefits of this calendar will be allocated to the financing of the Centre for adults with intellectual disabilities “ 3 olives ” that the Foundation will be opened in 2012

Madrid, November of 2011- the life expectancy of people with Down syndrome and other intellectual disabilities is, fortunately, more and more. To also increase the quality of life in the adult stage of these people, the Foundation, Down syndrome, Madrid offers resources and projects adapted to their needs for support.

Among them, is construction and commissioning of “ 3 olives ”, a care center for adults with disabilities which reinforces the work the FSDM usually conducted with these people. The Centre will include a residence and centralize, in addition, other resources such as training and insertion for working life, psychological and pedagogical advice, school families, and so on. All this is aimed at supporting people with intellectual disabilities since the beginning of the adult stage and throughout his life.

To contribute to the financing of this Centre, the FSDM and Navarro stylists have launched an initiative through the creation of “ twelve Cinderellas by 2012 ”. It is a schedule in the form of short story in which a group of children with intellectual disabilities and more than 20 artists participated: Pastora Vega, Dafne Fernández, rain red Esmeralda Moya, Ana Fernández, Jesús Vázquez, Laura Sanchez, Manuela Velasco, Carolina Cerezuela, Adriá ColladoVanesa Romero, Aida Folch, Elisa Mouliaá, Maria Adanez, Elena Furiase, Ricardo Gomez, Juan Postigo, Noelia Lopez Vidal, Eloy Azorín, Laura Pamplona, Pablo Castañón and Patricia Vico give life to the characters of Cinderella. Singer Ana Belén acts as godmother of the project with photographs of Joan Crisol, illustrations by Peter Hergar, Leo Cerrud texts and the work of the entire team of stylists Navarro.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips